Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature

A 45-year-old woman with a history of lung adenocarcinoma treated with osimertinib developed purpuric plaques and vesicles on the lower extremities after 5 months of therapy. Skin biopsy revealed leukocytoclastic vasculitis (LCV). A workup for systemic involvement was unremarkable. The patient was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Iriarte, Christopher, Young, Jonathan H., Rabin, Michael S., LeBoeuf, Nicole R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579488/
https://www.ncbi.nlm.nih.gov/pubmed/36275908
http://dx.doi.org/10.1016/j.jtocrr.2022.100415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579488/
https://www.ncbi.nlm.nih.gov/pubmed/36275908
http://dx.doi.org/10.1016/j.jtocrr.2022.100415

Ejemplares similares